The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,184,464 in first-year total cost, median $236,658.
Most frequent study sections
- HIV Coinfections and HIV Associated Cancers Study Section[HCAC]3
- HIV Comorbidities and Clinical Studies Study Section[HCCS]1
- Special Emphasis Panel[ZRG1 IDIB-M (02)]1
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY2
- DREXEL UNIVERSITY1
- EAST TENNESSEE STATE UNIVERSITY1
- UNIVERSITY OF CINCINNATI1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Unraveling sources of hepatitis B surface antigen before and after nucleos(t)ide analogue treatment in People with HIV1R21AI157760-01 | BALAGOPAL, ASHWINTHIO, CHLOE L | JOHNS HOPKINS UNIVERSITY, MD | $245,625 | HCAC |
| 2021 | Identifying the source of hepatitis B surface antigen in people with hepatitis B-HIV co-infection1R21AI165166-01 | BALAGOPAL, ASHWINTHIO, CHLOE L | JOHNS HOPKINS UNIVERSITY, MD | $245,625 | ZRG1 |
| 2021 | Biomarkers of Replication and Injury in HBV/HIV1R21AI165171-01 | SHERMAN, KENNETH E | UNIVERSITY OF CINCINNATI, OH | $236,658 | HCCS |
| 2021 | Dual specific gene editing drugs delivered by nanoparticles targeting HBV/HIV coinfection1R21AI157909-01 | YAO, ZHI Q. | EAST TENNESSEE STATE UNIVERSITY, TN | $234,224 | HCAC |
| 2021 | HIV Tat and HBV HBx in HIV/HBV Coinfection-associated Liver Disease1R21AI158024-01 | BOUCHARD, MICHAEL J.NONNEMACHER, MICHAEL R | DREXEL UNIVERSITY, PA | $222,332 | HCAC |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.